home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  September 26, 2016
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 648 active entries

SignalChem

Unit 550 5600 Parkwood Way
Richmond, BC V6V 2M2
Canada

Phone: 604-232-4600
Fax: 604-232-4601

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

SignalChem is a biotechnology company focused on the research, development and production of innovative cell signaling products to advance basic research and drug discovery efforts, with specific emphasis on the production of highly purified biologically active human recombinant proteins. Cellular signaling or the mechanism by which a cell transmits its signals inwards, ultimately producing a specific biological response, is of fundamental clinical importance. It is well documented that aberrations in these discrete pathways have been linked to the development of a variety of human diseases including cancer, cardiovascular disease, metabolic disorders, neurodegenerative disease and inflammatory conditions amongst others. With the recent success of signal transduction inhibitors in the clinic, there is an intensive effort to identify ‘targets’ linked with the pathogenesis of a human disease and to develop selective molecules to perturb these ‘targets’ in an effort to improve patient prognosis and minimize the non-specific systemic side-effects associated with generalized treatment modalities. The founders and scientific members of SignalChem have the knowledge to understand the architecture and biology of these discrete signaling pathways and to leverage this expertise to bring value-added products to the market. SignalChem is emerging as a leader and a key contender in the life science recombinant protein market place. SignalChem’s core product areas include: active human protein kinases, active human protein phosphatases, active human phosphodiesterases, unactive signaling proteins, isoform specific antibodies, primary antibodies, secondary antibodies, tag antibodies, assay kits and biologically relevant kinase and phosphatase substrates.

Selected Categories:

Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Supplier
- General
- Research
Contract
- Production
- Services

Last update of this entry: January 26, 2010

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.